Related Experiment Video
Updated: May 21, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity
Sang Hui Chu1, Ji-Hye Park, Mi Kyung Lee
1Department of Clinical Nursing Science, Yonsei University College of Nursing, Nursing policy and Research Institute, Biobehavioral Research Center, Seoul, Korea.
Insights
Pentraxin-3 (PTX3) levels are linked to lower insulin resistance in obese children. Increased PTX3 after physical activity correlates with improved insulin sensitivity, suggesting PTX3’s role in metabolic health.
Area of Science:
- Biochemistry and Metabolism
- Pediatric Endocrinology
Background:
- The role of pentraxin-3 (PTX3) in insulin resistance development remains unclear.
- Investigating PTX3's association with insulin resistance and its modulation by physical activity is crucial for understanding pediatric metabolic health.
Purpose of the Study:
- To determine if circulating PTX3 levels correlate with insulin resistance in overweight/obese children.
- To assess if changes in PTX3 levels following physical activity are associated with improvements in insulin resistance.
Main Methods:
- Fifty-seven overweight or obese children (mean age 12.04 years) participated in a controlled study.
- Physical activity and caloric intake were standardized, with baseline measurements of PTX3 and insulin resistance markers.
- Changes in PTX3 and insulin resistance were analyzed post-intervention.
Main Results:
- Baseline PTX3 levels showed a negative correlation with fasting insulin and HOMA-IR, independent of BMI and Tanner stage.
- Changes in PTX3 levels after physical activity were significantly associated with changes in fasting insulin and HOMA-IR.
- Children with increased PTX3 levels exhibited greater HOMA-IR improvement compared to those with decreased levels.
Conclusions:
- Pentraxin-3 (PTX3) is negatively associated with insulin resistance in overweight and obese children.
- PTX3 levels are dynamically associated with insulin resistance changes induced by physical activity, highlighting its potential role in metabolic regulation.
Background:
The role of pentraxin-3 (PTX3) in the development of insulin resistance is still not clear. We aimed to test 1) whether circulating PTX3 levels are associated with insulin resistance and 2) whether changes in PTX3 levels after the physical activity are associated with changes in insulin resistance.
Methods:
Fifty-seven overweight or obese children (39 boys, 18 girls; age: 12.04±0.82y, BMI: 26.5±1.2 kg/m²) participated in the study. All participants were housed together and their amount of physical activity (1823.5±1.34 kcal/day) and food intake (1882±68.8 kcal/day) were tightly controlled.
Results:
Circulating PTX3 levels at baseline were negatively associated with fasting insulin (r=-.336, p=0.012) and homeostasis model assessment of insulin resistance (HOMA-IR) (r=-.334, p=0.014) even after adjustment for BMI and Tanner stage. The degree of change in PTX3 levels notably associated with changes in fasting insulin (r=-.280, p=0.035) and HOMA-IR (r=-.281, p=.034) in response to the physical activity intervention. Subgroup analysis further indicates that HOMA-IR was improved more in subjects whose PTX3 levels were increased compared with subjects who PTX3 levels were decreased (HOMA-IR delta: -2.33±1.3 vs -1.46±0.70, p=0.004).
Conclusion:
PTX3 is negatively associated with insulin resistance and associated with changes in insulin resistance induced by physical activity in overweight and obese children.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
09:48Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Related Concept Videos
Obesity
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Insulin: The Receptor and Signaling Pathways